USG Programs

On March 15, 2025, the President signed a full-year “continuing resolution” (CR) that continues funding the federal government through the rest of the fiscal year. It maintains U.S. global health funding at the prior year (FY 2024) level ($10.8 billion).[i] The Full-Year Continuing Appropriations and Extensions Act, 2025, which was…

This brief identifies time-bound PEPFAR authorities and also provides a detailed side-by-side comparison of PEPFAR’s authorizing legislation over time.

This brief offers an overview of the new multilateral global health financing mechanism known as the Pandemic Fund, which is housed at the World Bank. The brief reviews the evolution of the Fund, its current financial status and donors, U.S. engagement, and policy issues going forward.

These figures provide a general overview of U.S. funding for global health.

Explore an overview of the Mexico City Policy, which, when in effect, requires foreign NGOs to certify that they will not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition for receiving U.S. government global health assistance.

PEPFAR, the U.S. global HIV/AIDS program, is – for the first time in its two-decade history – facing significant challenges that could impede its ability to fulfill its mission. This policy brief provides an overview of recent events and ongoing challenges facing the program.

This fact sheet provides an overview of the history of the Kemp-Kasten amendment, which states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization,” and examines its current application. Since enacted in 1985, Kemp-Kasten has often been used to withhold funding from the United Nations Population Fund (UNFPA).

This literature review identifies studies examining the impact of the Mexico City Policy, from 2001 to the present, with particular focus on capturing recent studies assessing the policy under the Trump administration.

This dashboard monitors the status of the U.S. President’s Malaria Initiative’s (PMI) partner countries’ progress toward global malaria targets.

This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 54 countries and tracks progress against 6 different indicators.